159 related articles for article (PubMed ID: 11274244)
1. Effects of losartan and amlodipine on intrarenal hemodynamics and TGF-beta(1) plasma levels in a crossover trial in renal transplant recipients.
Iñigo P; Campistol JM; Lario S; Piera C; Campos B; Bescós M; Oppenheimer F; Rivera F
J Am Soc Nephrol; 2001 Apr; 12(4):822-827. PubMed ID: 11274244
[TBL] [Abstract][Full Text] [Related]
2. Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy.
Campistol JM; Iñigo P; Larios S; Bescos M; Oppenheimer F
Nephrol Dial Transplant; 2001; 16 Suppl 1():114-6. PubMed ID: 11369837
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin II receptor blocker on plasma levels of TGF-beta 1 and interstitial fibrosis in hypertensive kidney transplant patients.
el-Agroudy AE; Hassan NA; Foda MA; Ismail AM; el-Sawy EA; Mousa O; Ghoneim MA
Am J Nephrol; 2003; 23(5):300-6. PubMed ID: 12904684
[TBL] [Abstract][Full Text] [Related]
4. Effect of losartan and amlodipine on proteinuria and transforming growth factor-beta1 in patients with IgA nephropathy.
Park HC; Xu ZG; Choi S; Goo YS; Kang SW; Choi KH; Ha SK; Lee HY; Han DS
Nephrol Dial Transplant; 2003 Jun; 18(6):1115-21. PubMed ID: 12748343
[TBL] [Abstract][Full Text] [Related]
5. Losartan decreases plasma levels of TGF-beta1 in transplant patients with chronic allograft nephropathy.
Campistol JM; Iñigo P; Jimenez W; Lario S; Clesca PH; Oppenheimer F; Rivera F
Kidney Int; 1999 Aug; 56(2):714-9. PubMed ID: 10432413
[TBL] [Abstract][Full Text] [Related]
6. Antiproteinuric efficacy of losartan in comparison with amlodipine in non-diabetic proteinuric renal diseases: a double-blind, randomized clinical trial.
Praga M; Andrade CF; Luño J; Arias M; Poveda R; Mora J; Prat MV; Rivera F; Galceran JM; Ara JM; Aguirre R; Bernis C; Marín R; Campistol JM
Nephrol Dial Transplant; 2003 Sep; 18(9):1806-13. PubMed ID: 12937228
[TBL] [Abstract][Full Text] [Related]
7. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of losartan and amlodipine regarding long-term blood pressure, cardiac and renal protection.
Peng F; Lin J; Lin L; Tang H
Int J Mol Med; 2012 Dec; 30(6):1376-86. PubMed ID: 23064712
[TBL] [Abstract][Full Text] [Related]
8. Divergent effects of calcium channel and angiotensin converting enzyme blockade on glomerulotubular function in cyclosporine-treated renal allograft recipients.
Sennesael JJ; Lamote JG; Violet I; Tasse S; Verbeelen DL
Am J Kidney Dis; 1996 May; 27(5):701-8. PubMed ID: 8629631
[TBL] [Abstract][Full Text] [Related]
9. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels.
Agarwal R; Siva S; Dunn SR; Sharma K
Am J Kidney Dis; 2002 Mar; 39(3):486-92. PubMed ID: 11877567
[TBL] [Abstract][Full Text] [Related]
10. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T;
Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
[TBL] [Abstract][Full Text] [Related]
11. Renal effects of losartan and amlodipine in hypertensive patients with non-diabetic nephropathy.
Holdaas H; Hartmann A; Berg KJ; Lund K; Fauchald P
Nephrol Dial Transplant; 1998 Dec; 13(12):3096-102. PubMed ID: 9870472
[TBL] [Abstract][Full Text] [Related]
12. Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients.
Gómez-Garre D; Martín-Ventura JL; Granados R; Sancho T; Torres R; Ruano M; García-Puig J; Egido J
Kidney Int; 2006 Apr; 69(7):1237-44. PubMed ID: 16482098
[TBL] [Abstract][Full Text] [Related]
13. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R
Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569
[TBL] [Abstract][Full Text] [Related]
14. Impact of therapy initiation with amlodipine or losartan on hemodynamic endpoints and JNC-VI blood pressure stage.
Putnam D; Griffis D; McLaughlin TP; Arocho R; Tang S
Am J Ther; 2006; 13(2):94-100. PubMed ID: 16645423
[TBL] [Abstract][Full Text] [Related]
15. Effect of losartan on slowing progression of chronic allograft nephropathy.
Wang PX; Fan MQ; Huang CB; Feng JY; Xiao Y; Fang ZQ; Zhang YP
Chin Med Sci J; 2005 Dec; 20(4):231-6. PubMed ID: 16422249
[TBL] [Abstract][Full Text] [Related]
16. Influence of AT1 receptor blockade on blood pressure, renal haemodynamics and hormonal responses to intravenous angiotensin II infusion in hypertensive patients.
Fridman KU; Elmfeldt D; Wysocki M; Friberg PR; Andersson OK
Blood Press; 2002; 11(4):244-52. PubMed ID: 12361194
[TBL] [Abstract][Full Text] [Related]
17. Renal effects of long-term leptin infusion and preventive role of losartan treatment in rats.
Gunduz Z; Dursun N; Akgun H; Ozturk F; Okur H; Koc N
Regul Pept; 2005 Dec; 132(1-3):59-66. PubMed ID: 16229907
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of angiotensin II receptor antagonist on autoregulation of zonal glomerular filtration rate in renovascular hypertensive rats.
Wang X; Aukland K; Iversen BM
Kidney Blood Press Res; 1997; 20(4):225-32. PubMed ID: 9398027
[TBL] [Abstract][Full Text] [Related]
19. [Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)].
Shibasaki Y; Nishiue T; Masaki H; Matsubara H; Iwasaka T
Nihon Rinsho; 2002 Oct; 60(10):1992-8. PubMed ID: 12397697
[TBL] [Abstract][Full Text] [Related]
20. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
Dumont Y; D'Amours M; Lebel M; Larivière R
J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
